Abstract:Background: Ovarian cancer presents a substantial risk to women's health and lives, with early detection and treatment proving challenging. Targeted nanodelivery systems are viewed as a promising approach to enhance the effectiveness of ovarian cancer treatment and ultrasonic imaging outcomes. Objective: A phase-shifted nanodelivery system (NPs) loaded with paclitaxel (PTX) and further conjugated with avidin (Ab) was studied, with the goal of investigating the effects of targeted nanodelivery strategies on the in vitro therapeutic efficacy and ultrasonic imaging of ovarian cancer. This study provides a foundation for future in vivo treatments utilizing this approach. Methods: PTX-NPs were prepared using the single water-in-oil (O/W) emulsion solvent evaporation method, with avidin coupling achieved through biotin-avidin affinity. The encapsulation efficiency and release profile of PTX were analyzed using UV spectrophotometry. The phase-shift properties of the Ab-PTX-NPs delivery system were evaluated, and the targeting efficiency, cytotoxicity against SKOV3 cells, and in vivo biosafety of various nanodelivery systems were assessed. Results: The prepared nanodelivery system showed a stable and uniform structure with a good particle size distribution and exhibited favorable release characteristics under ultrasound exposure. In vitro experiments revealed that the nanodelivery system displayed excellent targeting and cytotoxic effects against SKOV3 cells, indicating the potential of the Ab-PTX-NPs delivery system for targeted ovarian cancer therapy. In vivo safety studies demonstrated the high biosafety of the prepared nanodelivery system. Conclusion: A novel nanodelivery system was developed, and the experimental results obtained provide a solid experimental basis for further research on in vivo ultrasound molecular imaging technology, offering new insights into targeted ultrasound molecular imaging and the treatment of ovarian cancer.

The feasibility study of M-MSNs used as gene carrier in ovarian cancer

Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy.

Development of Magnetic Nanoparticles with Double Silica Shells of Different Porosities for Efficient Sirna Delivery to Breast Cancer Cells

A Mesoporous Silica Nanoparticle--pei--fusogenic Peptide System for Sirna Delivery in Cancer Therapy.

Highly Effective Inhibition of Lung Cancer Growth and Metastasis by Systemic Delivery of Sirna Via Multimodal Mesoporous Silica-Based Nanocarrier.

Mesoporous core-shell silica nanoparticles with anti-fouling properties for ovarian cancer therapy

Construction of Magnetic Small Interfering RNA Nanoparticles and Effects of Its Transfection on Silencing Survivin Gene Expression and Inducing Human Bladder Cancer Cell Apoptosis

Magnetically guided survivin-siRNA delivery and simultaneous dual-modal imaging visualization based on Fe3O4@mTiO2 nanospheres for breast cancer.

Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.

Reversal of Ovarian Cancer Multidrug Resistance by a Combination of LAH4-L1-siMDR1 Nanocomplexes with Chemotherapeutics

Systemic Delivery Of Therapeutic Sirna By Multifunctional Mesoporous Silica-Based Nanocarrier Inhibits Lung Cancer Growth And Metastasis

Polyetherimide-Grafted Fe3o4@Sio2 Nanoparticles As Theranostic Agents for Simultaneous Vegf Sirna Delivery and Magnetic Resonance Cell Imaging

X-Linked Inhibitor of Apoptosis Protein (Xiap)-Loaded Magnetic Mesoporous Silica Nanoparticles Incorporated with Mir-233 to Improve Radio Sensitization of Cervical Cancer Cells and Promote Apoptosis.

Dual-mode US/MRI Nanoparticles Delivering Sirna and Pt(iv) for Ovarian Cancer Treatment

Magnetic Cationic Amylose Nanoparticles Used to Deliver Survivin-Small Interfering RNA for Gene Therapy of Hepatocellular Carcinoma In Vitro

Cell-penetrating Magnetic Nanoparticles for Highly Efficient Delivery and Intracellular Imaging of Sirna.

Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine

Tumor specific delivery with redox-triggered mesoporous silica nanoparticles inducing neovascularization suppression and vascular normalization

Folate-Functionalized Magnetic-Mesoporous Silica Nanoparticles for Drug/Gene Codelivery to Potentiate the Antitumor Efficacy.

The Packaging of Sirna Within the Mesoporous Structure of Silica Nanoparticles

Mesothelin-Mediated Paclitaxel Phase-Shifted Nanodelivery System for Molecular Ultrasound Imaging and Targeted Therapy Potential in Ovarian Cancer